Our markets
Four markets. One way of working.
Oxalas operates in the United States, Saudi Arabia, the United Arab Emirates and Egypt. In each we work within the local regulatory framework, with local distribution partners and with local safety reporting.
United States
Regulatory framework · U.S. Food and Drug Administration (FDA)
Our U.S. activity spans prescription and over-the-counter medicines and dietary supplements, under federal requirements and the state rules that apply to distribution and pharmacy supply.
Saudi Arabia
Regulatory framework · Saudi Food and Drug Authority (SFDA)
Products are registered with the SFDA and supplied through licensed Saudi partners, with Arabic and English patient information and local pharmacovigilance reporting.
United Arab Emirates
Regulatory framework · Ministry of Health and Prevention (MOHAP)
Federal registration and supply through licensed UAE distributors, serving pharmacies and healthcare providers across the Emirates.
Egypt
Regulatory framework · Egyptian Drug Authority (EDA)
Registration, supply and pharmacovigilance for one of the region’s largest patient populations, with local partners for distribution to pharmacies nationwide.
Working with us in your market
Distributors, pharmacies and healthcare professionals in any of our four markets can reach us through the contact page. Please mention your country so the right team answers.